Clinical trials are also conducted in ideal medical settings, which cant always be replicated outside of these conditions
Semaglutide reduced ELF score and VCTE-measured liver stiffness, and improved N-terminal type III collagen propeptide (PRO-C3) and the FibroScan-AST (FAST) score, markers associated with fibrotic activity and risk stratification in MASLD [7,13,14]
Evaluate the change in BMI after 12 weeks on the maintenance dose and discontinue SAXENDA if the patient has not had a reduction in BMI of at least 1% from baseline, since it is unlikely that the patient will achieve and sustain clinically meaningful weight loss with continued treatment
A key repressive mark, H3K27me3, is catalyzed by EZH2, a core component of the polycomb repressive complex 2 (PRC2)
This indicates this peptide to have significant cardiac properties
The fact that they were both Arctic explorers could bias it, but it's a revelation one way or the other